Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction

Journal of Hypertension

Volumn 24, Issue 10, 2006, Pages 1965-1970

  Mayer, Björn ^a   Lieb, Wolfgang ^a   Götz, Anika ^a   König, Inke R ^a   Kauschen, Lena F ^a   Linsel Nitschke, Patrick ^a   Pomarino, Andrea ^a   Holmer, Stephan ^b   Hengstenberg, Christian ^b   Doering, Angela ^c   Loewel, Hannelore ^c   Hense, Hans Werner ^d   Ziegler, Andreas ^a   Erdmann, Jeanette ^a   Schunkert, Heribert ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Association; CYP4A11; Genetics; Hypertension; Left ventricular structure; Myocardial infarction; Polymorphism

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450 4A11; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

EID: 33748546940     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000244944.34546.8e     Document Type: Article

References (25)

1. Flack JM, Neaton J, Grimm R Jr, Shih J, Cutler J, Ensrud K, et al. Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation 1995; 92:2437-2445.
2. Hengstenberg C, Schunkert H, Mayer B, Doring A, Lowel H, Hense HW, et al. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 2001; 49:820-827.
3. Luft FC. Hypertension as a complex genetic trait. Semin Nephrol 2002; 22:115-126.
4. Eriksson AL, Skrtic S, Niklason A, Hulten LM, Wiklund O, Hedner T, et al. Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population. Eur Heart J 2004; 25:386-391.
5. Nakayama T, Soma M, Sato N, Haketa A, Kosuge K, Aoi N, et al. An association study in essential hypertension using functional polymorphisms in lymphotoxin-alpha gene. Am J Hypertens 2004; 17:1045-1049.
6. Toka HR, Luft FC. Monogenic forms of human hypertension. Semin Nephrol 2002; 22:81-88.
7. Schunkert H, Hense HW, Doring A, Riegger GA, Siffert W. Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998; 32:510-513.
8. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998; 18:45-48.
9. Zhang X, Erdmann J, Regitz-Zagrosek V, Kurzinger S, Hense HW, Schunkert H. Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene. J Hypertens 2000; 18:267-272.
10. Mayer B, Schunkert H. ACE gene polymorphism and cardiovascular diseases. Herz 2000; 25:1-6.
11. Gainer JV, Bellamine A, Dawson EP, Womble KE, Grant SW, Wang Y, et al. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 2005; 111:63-69.
12. Mayer B, Lieb W, Gotz A, Konig IR, Aherrahrou Z, Thiemig A, et al. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. Hypertension 2005; 46:766-771.
13. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 1988; 41:105-114.
14. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4:1222-1230.
15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
16. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37:7-11.
17. Wellek S. Tests for establishing compatibility of an observed genotype distribution with Hardy-Weinberg equilibrium in the case of a biallelic locus. Biometrics 2004; 60:694-703.
18. Royston P, Sauerbrei W. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials. Stat Med 2004; 23:2509-2525.
19. Carroll MA, McGiff JC. A new class of lipid mediators: cytochrome P450 arachidonate metabolites. Thorax 2000; 55 (Suppl 2):S13-S16.
20. Roman RJ, Ma YH, Frohlich B, Markham B. Clofibrate prevents the development of hypertension in Dahl salt- sensitive rats. Hypertension 1993; 21:985-988.
21. Capdevila JH, Falck JR. The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. Biochem Biophys Res Commun 2001; 285:571-576.
22. McGiff JC, Quilley J. 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr Opin Nephrol Hypertens 2001; 10:231-237.
23. Ji Q, Ikegami H, Fujisawa T, Kawabata Y, Ono M, Nishino M, et al. A common polymorphism of uncoupling protein 2 gene is associated with hypertension. J Hypertens 2004; 22:97-102.
24. Pereira AC, Floriano MS, Mota GF, Cunha RS, Herkenhoff FL, Mill JG, et al. Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension 2003; 42:685-692.
25. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002; 32:650-654.